Navigation Links
The Apothecary Shops Receives Exclusive Distribution Rights for Mitosol®
Date:2/17/2012

PHOENIX, Feb. 17, 2012 /PRNewswire-iReach/ -- Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol® (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.

The Mitosol® Kit for Ophthalmic Use provides ophthalmic surgeons a new means of delivering a precise dose of its active ingredient, mitomycin-c, for use in glaucoma surgical procedures, without requiring a change to existing surgical technique.   Last week, Mitosol® was approved by the Food and Drug Administration for use in as an antimetabolite indicated  as an adjunct to ab externo glaucoma surgery. ( See full prescribing information at  )

"The approval of Mitosol® for use in glaucoma surgery represents the culmination of years of work on the part of Mobius Therapeutics™," said Ed Timm, President of Mobius Therapeutics™.  "It will provide surgeons, hospitals and patients with enhanced convenience, safety and consistency in the surgical treatment of glaucoma."

Since opening its first location in Arizona in 1996, The Apothecary Shops has focused on specific disease states, including ophthalmology, and has vast experience in providing medications for patients with eye-related illnesses and diseases.  To best serve their patients, The Apothecary Shops has a dedicated ophthalmology sales and pharmacist team, VAWD Accreditation, and a wholesale division for office ordering.

"The Apothecary Shops is the ideal partner to distribute Mitosol®," said Ed Timm, President and CEO of Mobius Therapeutics.  "Their expertise and deep understanding of ophthalmology combined with exceptional customer service levels gives us great confidence in their ability to provide the market an uninterrupted source of supply and a superior customer experience."

"We're proud to be selected by Mobius Therapeutics as the exclusive distribution partner for this very important new drug, and better serve our customers", said Sheri Garver, Apothecary Shop Wholesale Director.

Glaucoma is the second-leading cause of blindness in the United States; it is incurable and loss of vision is irreversible.  Once diagnosed, medication and/or surgery may halt further loss of vision.  Although often thought of as a disease that affects the elderly, glaucoma strikes people of all ages.  The best way to protect your sight from glaucoma is to get tested, and if diagnosed, begin treatment immediately. (Source: Glaucoma Resource Foundation website, February, 2012)

About The Apothecary Shop Wholesale, Inc.

Apothecary Shop Wholesale is a VAWD accredited wholesaler affiliated with a national specialty pharmacy, The Apothecary Shops, which has provided individualized care and support to patients since 1996.  Specialties include ophthalmology, oncology, infectious diseases, including HIV/AIDS and hepatitis, fertility, pain management, women's health, and transplant-related medicines.  The Apothecary Shops' clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The Apothecary Shops offer a nationwide specialty national distribution service to complement 16 physical locations. For more information, visit: www.theapothecaryshop.com.

About Mobius Therapeutics, LLC

Mobius Therapeutics, LLC is a St. Louis-based commercial stage venture focused on ophthalmic surgery solutions.  Its first product, Mitosol®, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery.   The glaucoma indication is in active commercialization; the refractive and corneal indications are awaiting approval by the Food and Drug Administration. For more information, visit: www.mobiustherapeutics.com.

Media Contact:

Jackie Wright Rainmaker Integrated, 480-361-4348, jackie@rmimpr.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Apothecary Shop Wholesale, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiarys Stock to Investors
2. The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders
3. FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010
4. BioStorage Technologies to Sponsor and Present Educational Workshops at Annual Biorepositories Conference
5. Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches by the U.S. FDA Commissioner, U.S. CMS Administrator, CBS Evening News Anc
6. AdvaMed 2010 Premier Medical Technology Conference Opens Today in Washington D.C. With Executive Workshops, Company Presentations, Innovation Alley Exhibits and Featured Keynote Speakers: FDA Commissioner Dr. Margaret Hamburg, CMS Administrator Dr.
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
11. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):